Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study
Luca Valerio,Anna C Mavromanoli,Stefano Barco,Christina Abele,Dorothea Becker,Leonhard Bruch,Ralf Ewert,Martin Faehling,David Fistera,Felix Gerhardt,Hossein Ardeschir Ghofrani,Aleksandar Grgic,Ekkehard Grünig,Michael Halank,Matthias Held,Lukas Hobohm,Marius M Hoeper,Frederikus A Klok,Mareike Lankeit,Hanno H Leuchte,Nadine Martin,Eckhard Mayer,F Joachim Meyer,Claus Neurohr,Christian Opitz,Kai Helge Schmidt,Hans Jürgen Seyfarth,Rolf Wachter,Heinrike Wilkens,Philipp S Wild,Stavros V Konstantinides,Stephan Rosenkranz,FOCUS Investigators,Brunhilde Fischer,Anja Käberich,Karsten Keller,Silke Otto,Kurt Quitzau,Kathrin Rost,Kai-Helge Schmidt,Doris Schöneberger,Stefanie Geistert,Katrin Schüler,Claudia Pohl,Jeannette Pieper,Birgit Blaich,Annika Landmesser,Jasmin Rudolph,Sibel Gün,Hossein-Ardeschir Ghofrani,Ute George,Benjamin Egenlauf,Amina Salkić,Eva-Maria Heier,Kristin Tausche,Tina Rink,Diana Jäkel,Barbara Schröder,Julia Freise,Susanne Tayler,Annika Horn,Dagmar Emge-Rossa,Karine Thabaret,Juergen Barton,Ines Bressem,Hans-Jürgen Seyfarth,Patricia Berger,Angela Hennig,Kristian Hellenkamp,Carmen Sentler,Martina Schulte,Franziska Trudzinski,Ines Holtz
DOI: https://doi.org/10.1093/eurheartj/ehac206
2022-09-21
Abstract:Aims: To systematically assess late outcomes of acute pulmonary embolism (PE) and to investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively defined criteria. Methods and results: A prospective multicentre observational cohort study was conducted in 17 large-volume centres across Germany. Adult consecutive patients with confirmed acute symptomatic PE were followed with a standardized assessment plan and pre-defined visits at 3, 12, and 24 months. The co-primary outcomes were (i) diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH), and (ii) PPEI, a combination of persistent or worsening clinical, functional, biochemical, and imaging parameters during follow-up. A total of 1017 patients (45% women, median age 64 years) were included in the primary analysis. They were followed for a median duration of 732 days after PE diagnosis. The CTEPH was diagnosed in 16 (1.6%) patients, after a median of 129 days; the estimated 2-year cumulative incidence was 2.3% (1.2-4.4%). Overall, 880 patients were evaluable for PPEI; the 2-year cumulative incidence was 16.0% (95% confidence interval 12.8-20.8%). The PPEI helped to identify 15 of the 16 patients diagnosed with CTEPH during follow-up (hazard ratio for CTEPH vs. no CTEPH 393; 95% confidence interval 73-2119). Patients with PPEI had a higher risk of re-hospitalization and death as well as worse quality of life compared with those without PPEI. Conclusion: In this prospective study, the cumulative 2-year incidence of CTEPH was 2.3%, but PPEI diagnosed by standardized criteria was frequent. Our findings support systematic follow-up of patients after acute PE and may help to optimize guideline recommendations and algorithms for post-PE care.